BEAM – beam therapeutics inc. (US:NYSE)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

BEAM

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/17

07:32 am

beam

Beam Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]

Low Report

Beam Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]

Report

12/17

07:00 am

beam

Beam Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Medium Report

Beam Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Report

12/11

07:17 am

beam

Beam Therapeutics Inc. (NASDAQ: BEAM) was upgraded by analysts at Cantor Fitzgerald to a "hold" rating.

Medium Report

Beam Therapeutics Inc. (NASDAQ: BEAM) was upgraded by analysts at Cantor Fitzgerald to a "hold" rating.

Report

12/9

06:22 pm

beam

Beam Therapeutics Inc. (NASDAQ: BEAM) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $57.00 price target on the stock.

Medium Report

Beam Therapeutics Inc. (NASDAQ: BEAM) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $57.00 price target on the stock.

Report

12/9

12:54 pm

beam

Beam Therapeutics Inc. (NASDAQ: BEAM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.

Low Report

Beam Therapeutics Inc. (NASDAQ: BEAM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.

Report

12/9

11:15 am

beam

Beam Therapeutics Unveils New Safety, Efficacy Data From Sickle Cell Disease Candidate, Stock Gains [Yahoo! Finance]

Low Report

Beam Therapeutics Unveils New Safety, Efficacy Data From Sickle Cell Disease Candidate, Stock Gains [Yahoo! Finance]

Report

12/9

09:56 am

beam

Beam Therapeutics Appoints Sravan Emany as New CFO, Shares Up [Yahoo! Finance]

Low Report

Beam Therapeutics Appoints Sravan Emany as New CFO, Shares Up [Yahoo! Finance]

Report

12/8

01:50 pm

beam

Beam Therapeutics Presents New Non-human Primate (NHP) Data Demonstrating Proof-of-concept for ESCAPE, a Non-genotoxic, Antibody-based Conditioning Approach to Treating Sickle Cell Disease, at American Society of Hematology (ASH) Annual Meeting [Yahoo! Fi

Low Report

Report

Date

Time

Symbol

Company Name

Action

%Chg

11/5/2024

06:30 am

beam

beam therapeutics inc.

MISS Report

-1.8%

beam therapeutics inc.

Report

5/7/2024

06:30 am

beam

beam therapeutics inc.

BEAT Report

-2.0%

beam therapeutics inc.

Report

2/27/2024

06:30 am

beam

beam therapeutics inc.

BEAT Report

25.9%

beam therapeutics inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

12/11

07:17 am

Upgrades

Hold

Cantor Fitzgerald

Medium

Report

-4.3%

Report

12/9

06:22 pm

Reiterates

Outperform

Wedbush

Medium

Report

8.4%

Report

12/9

06:22 pm

Reiterates

Outperform

Wedbush

Medium

Report

8.4%

Report

12/9

12:54 pm

Reiterates

Buy

HC Wainwright

Low

Report

1.8%

Report

11/7

08:36 am

Reiterates

Buy

HC Wainwright

Low

Report

-1.1%

Report

11/6

10:58 am

Maintains

Sector Perform

RBC Capital

Low

Report

-0.1%

Report

11/6

10:58 am

Maintains

Sector Perform

RBC Capital

Low

Report

-0.1%

Report

11/6

07:32 am

Upgrades

Market Perform

Outperform

Leerink Partners

Medium

Report

6.5%

Report

Date

Time

Symbol

Headline

Impact

12/19

04:10 pm

beam

Form 4 Beam Therapeutics Inc. For: Dec 17 Filed by: Ciaramella Giuseppe

Medium Report

Form 4 Beam Therapeutics Inc. For: Dec 17 Filed by: Ciaramella Giuseppe

Report

12/19

04:05 pm

beam

Form 3 Beam Therapeutics Inc. For: Dec 19 Filed by: Emany Sravan Kumar

Medium Report

Form 3 Beam Therapeutics Inc. For: Dec 19 Filed by: Emany Sravan Kumar

Report

12/9

07:02 am

beam

Form 8-K Beam Therapeutics Inc. For: Dec 07

Low Report

Form 8-K Beam Therapeutics Inc. For: Dec 07

Report

12/6

07:07 am

beam

Form 8-K Beam Therapeutics Inc. For: Dec 05

Medium Report

Form 8-K Beam Therapeutics Inc. For: Dec 05

Report

12/4

07:23 am

beam

Form 4 Beam Therapeutics Inc. For: Dec 02 Filed by: Guindo Chirfi

Medium Report

Form 4 Beam Therapeutics Inc. For: Dec 02 Filed by: Guindo Chirfi

Report

12/4

07:19 am

beam

Form 3 Beam Therapeutics Inc. For: Dec 02 Filed by: Guindo Chirfi

Medium Report

Form 3 Beam Therapeutics Inc. For: Dec 02 Filed by: Guindo Chirfi

Report

12/4

07:09 am

beam

Form 8-K Beam Therapeutics Inc. For: Dec 02

Medium Report

Form 8-K Beam Therapeutics Inc. For: Dec 02

Report

11/12

09:51 am

beam

Form SC 13G/A Beam Therapeutics Inc. Filed by: FMR LLC

Medium Report

Form SC 13G/A Beam Therapeutics Inc. Filed by: FMR LLC

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.